vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Innovex International, Inc. (INVX). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $273.6M, roughly 1.3× Innovex International, Inc.). Innovex International, Inc. runs the higher net margin — 5.1% vs -0.8%, a 5.9% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 9.1%). Over the past eight quarters, Innovex International, Inc.'s revenue compounded faster (46.2% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
ASIX vs INVX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $273.6M |
| Net Profit | $-2.8M | $14.0M |
| Gross Margin | 7.6% | 28.9% |
| Operating Margin | -0.7% | 9.4% |
| Net Margin | -0.8% | 5.1% |
| Revenue YoY | 9.4% | 9.1% |
| Net Profit YoY | -892.9% | -56.1% |
| EPS (diluted) | $-0.11 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $273.6M | ||
| Q3 25 | $374.5M | $240.0M | ||
| Q2 25 | $410.0M | $224.2M | ||
| Q1 25 | $377.8M | $240.4M | ||
| Q4 24 | $329.1M | $250.7M | ||
| Q3 24 | $398.2M | $151.8M | ||
| Q2 24 | $453.5M | $130.3M | ||
| Q1 24 | $336.8M | $128.0M |
| Q4 25 | $-2.8M | $14.0M | ||
| Q3 25 | $-2.6M | $39.2M | ||
| Q2 25 | $31.4M | $15.3M | ||
| Q1 25 | $23.3M | $14.8M | ||
| Q4 24 | $352.0K | $31.8M | ||
| Q3 24 | $22.3M | $82.6M | ||
| Q2 24 | $38.9M | $9.5M | ||
| Q1 24 | $-17.4M | $16.4M |
| Q4 25 | 7.6% | 28.9% | ||
| Q3 25 | 6.8% | 31.6% | ||
| Q2 25 | 14.3% | 32.0% | ||
| Q1 25 | 14.2% | 31.8% | ||
| Q4 24 | 3.4% | 33.9% | ||
| Q3 24 | 14.4% | 34.7% | ||
| Q2 24 | 17.9% | 35.3% | ||
| Q1 24 | 0.9% | 38.4% |
| Q4 25 | -0.7% | 9.4% | ||
| Q3 25 | -0.9% | 26.0% | ||
| Q2 25 | 7.7% | 10.1% | ||
| Q1 25 | 7.7% | 9.1% | ||
| Q4 24 | -3.9% | 10.7% | ||
| Q3 24 | 7.5% | -8.7% | ||
| Q2 24 | 11.5% | 10.0% | ||
| Q1 24 | -7.0% | 17.4% |
| Q4 25 | -0.8% | 5.1% | ||
| Q3 25 | -0.7% | 16.3% | ||
| Q2 25 | 7.7% | 6.8% | ||
| Q1 25 | 6.2% | 6.1% | ||
| Q4 24 | 0.1% | 12.7% | ||
| Q3 24 | 5.6% | 54.4% | ||
| Q2 24 | 8.6% | 7.3% | ||
| Q1 24 | -5.2% | 12.8% |
| Q4 25 | $-0.11 | $0.20 | ||
| Q3 25 | $-0.10 | $0.57 | ||
| Q2 25 | $1.15 | $0.22 | ||
| Q1 25 | $0.86 | $0.21 | ||
| Q4 24 | $0.02 | $-0.03 | ||
| Q3 24 | $0.82 | $1.99 | ||
| Q2 24 | $1.43 | $0.30 | ||
| Q1 24 | $-0.65 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | — |
| Total DebtLower is stronger | — | $18.9M |
| Stockholders' EquityBook value | $815.2M | $1.1B |
| Total Assets | $1.7B | $1.3B |
| Debt / EquityLower = less leverage | — | 0.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $18.4M | — | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $12.1M | $185.6M | ||
| Q1 24 | $20.6M | $202.2M |
| Q4 25 | — | $18.9M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $34.8M | ||
| Q1 25 | — | $19.7M | ||
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $815.2M | $1.1B | ||
| Q3 25 | $818.2M | $1.0B | ||
| Q2 25 | $823.7M | $995.6M | ||
| Q1 25 | $794.4M | $978.4M | ||
| Q4 24 | $774.6M | $958.2M | ||
| Q3 24 | $766.4M | $904.4M | ||
| Q2 24 | $746.6M | $352.5M | ||
| Q1 24 | $713.2M | $344.3M |
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.6B | $1.2B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.5B | $1.0B | ||
| Q1 24 | $1.5B | $1.0B |
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $52.2M |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | 3.74× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $52.2M | ||
| Q3 25 | $26.6M | $48.4M | ||
| Q2 25 | $21.1M | $59.2M | ||
| Q1 25 | $11.4M | $31.1M | ||
| Q4 24 | $64.2M | $36.3M | ||
| Q3 24 | $57.3M | $21.7M | ||
| Q2 24 | $50.2M | $22.8M | ||
| Q1 24 | $-36.2M | $12.6M |
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | $16.6M | ||
| Q1 24 | $-71.6M | $7.8M |
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | 12.7% | ||
| Q1 24 | -21.3% | 6.1% |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | 4.7% | ||
| Q1 24 | 10.5% | 3.7% |
| Q4 25 | — | 3.74× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | 0.67× | 3.86× | ||
| Q1 25 | 0.49× | 2.11× | ||
| Q4 24 | 182.29× | 1.14× | ||
| Q3 24 | 2.57× | 0.26× | ||
| Q2 24 | 1.29× | 2.39× | ||
| Q1 24 | — | 0.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
INVX
| Products | $202.7M | 74% |
| Leasing | $42.3M | 15% |
| Services | $28.6M | 10% |
